The Claim
In women with obesity, a 1-month very-low-calorie ketogenic diet is associated with significant reductions in fasting serum insulin, triglycerides, total cholesterol, and LDL cholesterol, despite concurrent loss of lean tissue.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In women with obesity, following a very-low-calorie ketogenic diet for one month leads to measurable decreases in fasting insulin, triglycerides, total cholesterol, and LDL cholesterol, even as lean body mass is lost.
See the scientific wording
In women with obesity, a 1-month very-low-calorie ketogenic diet is associated with significant reductions in fasting serum insulin, triglycerides, total cholesterol, and LDL cholesterol, indicating improved metabolic markers despite concurrent lean tissue loss.
When a woman with obesity eats very few carbs and calories, her body stops using sugar for fuel and starts burning fat instead. This lowers insulin because there is no sugar to store, and the fat breakdown reduces the fat particles in the blood. At the same time, her body breaks down muscle to make glucose, which slows her metabolism. The combination of less insulin, less fat in the blood, and less muscle mass leads to lower cholesterol and triglycerides.
What the research says
1 studyAfter one month on a very low-calorie keto diet, obese women lost mostly fat and started burning fat for energy instead of carbs — which usually means better blood sugar and cholesterol levels, even though they also lost a little muscle.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.